SCHEMBL8996338

SCHEMBL8996338

COC(=O)c1cc(OC)c2c(c1)C(=O)c1cccc(OC)c1C2=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
ALDH1A1 P00352 2/20 0.55
TTR P02766 2/20 0.55
KDM4E B2RXH2 1/20 0.55
ABCC4 O15439 1/20 0.55
USP2 O75604 1/20 0.55
LMNA P02545 1/20 0.55
TP53 P04637 1/20 0.55
HSP90AA1 P07900 1/20 0.55
CHRM2 P08172 1/20 0.55
HSP90AB1 P08238 1/20 0.55
HTR1A P08908 1/20 0.55
ADRA2A P08913 1/20 0.55
ADORA3 P0DMS8 1/20 0.55
MAPT P10636 1/20 0.55
CHRM1 P11229 1/20 0.55
PKM P14618 1/20 0.55
HPGD P15428 1/20 0.55
SLC6A2 P23975 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8996312 0.87 TTR (0.71) MEN1KMT2AALDH1A1TTRKDM4E
SCHEMBL8996333 0.84 MEN1 (0.53) MEN1KMT2AALDH1A1TTRKDM4E
SCHEMBL5085838 0.81 KEAP1 (0.52) MEN1KMT2AALDH1A1TTRKDM4E
SCHEMBL8996374 0.81 EPHX2 (0.45) MEN1KMT2AALDH1A1TTRKDM4E
SCHEMBL21657713 0.80 TTR (0.47) MEN1KMT2AALDH1A1TTRKDM4E
SCHEMBL8947495 0.80 EGFR (0.73) MEN1KMT2AALDH1A1KDM4EUSP2
SCHEMBL15413441 0.80 MEN1 (0.49) MEN1KMT2AALDH1A1TTRKDM4E
Rhein Methylester SCHEMBL15427187 0.79 TDP1 (0.69) MEN1KMT2AALDH1A1TTRKDM4E
SCHEMBL30760702 0.79 SLC37A4 (0.55) MEN1KMT2AALDH1A1TTRKDM4E
SCHEMBL16921215 0.78 EGFR (0.52) MEN1KMT2AALDH1A1TTRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872474-B1 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF UNIV GEORGIA STATE RES FOUND (US) 2022-01-19 EP disclosed
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2020-01-28 US disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2015-07-23 US disclosed
WO-2014011753-A2 ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2014-01-16 WO disclosed
US-5480873-A ARTHRITIS LILLY INDUSTRIES LIMITED (GB) 1996-01-02 US disclosed
EP-0570091-A1 Anthraquinone derivatives, process for their preparation and their use as medicaments LILLY INDUSTRIES LIMITED (GB) 1993-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203442-A1 Anthraquinone Analogs and Methods of Making and Using Thereof PCNA, KRAS, RECQL MEN1 677/4885KMT2A 1122/4885ALDH1A1 1562/4885
US-10544090-B2 Anthraquinone analogs and methods of making and using thereof PCNA, KRAS, RECQL MEN1 677/4885KMT2A 1122/4885ALDH1A1 1562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.